USV acquires Wellbeing Nutrition

novozymes-acquires-microbiome-labs-for-125m

Expands footprint in India’s D2C nutraceutical market

USV has signed a definitive agreement to acquire 79 per cent equity stake in Nutritionalab (Wellbeing Nutrition) marking a strategic expansion into India’s fast-growing nutraceutical and consumer wellness space. With a six-decade legacy and leadership in the oral anti-diabetic and cardiovascular segments, USV has long been the trusted house of iconic pharma brands such as Glycomet GP, Ecosprin, Roseday and the exclusive partner for the globally acclaimed Sebamed range in India.

Prashant Tewari, Managing Director, USV said, “This acquisition dovetails strongly with our strategy to build a future-facing healthcare portfolio that responds to the changing aspirations of Indian consumers. Their success across channels, particularly through their own platform, and their premium, clinically backed portfolio positions us well to accelerate growth while maintaining high standards of quality, compliance, and ethics that USV has been known for. We look forward to unlocking the next phase of growth by leveraging USV’s global capabilities while preserving Wellbeing Nutrition’s core mission of transparent, sustainable, and high-quality nutrition.”

Avnish Chhabria, Founder and CEO, Wellbeing Nutrition, added, “This partnership with USV is a natural alignment of values, philosophy, and long-term intent. Wellbeing Nutrition was built on the belief that preventive health must be grounded in pharmaceutical-grade science, uncompromising quality, and deep consumer trust — principles that USV has stood for over decades. In USV, we have found a new home that understands the importance of scientific rigour, patient capital, and building enduring institutions. Together, we are committed to shaping a new benchmark for health and wellness, while preserving the integrity, culture, and purpose with which Wellbeing Nutrition was founded.”

Read Previous

General Mills India opens manufacturing plant in Nashik

Leave a Reply